Multicellular Biologics

Advertisement

cGxPJobs Banner

PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026

SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...

By cGxPwire Editor
September 30, 2026

Read More

PolarityBio Gains FDA Priority Review for SkinTE in DFUs

SALT LAKE CITY, Utah — September 15, 2026 PolarityBio announced that the U.S. Food and Drug Administration (FDA) has...

By cGxPwire Editor
September 16, 2026

Read More

Advertisement

cGxPJobs

Directory